Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetal Hemoglobin | 30 | 2023 | 342 | 8.230 |
Why?
|
Hematopoiesis | 30 | 2024 | 2050 | 7.020 |
Why?
|
Erythropoiesis | 28 | 2022 | 682 | 5.190 |
Why?
|
Hematopoietic Stem Cells | 25 | 2024 | 3387 | 3.940 |
Why?
|
GATA1 Transcription Factor | 15 | 2022 | 296 | 3.860 |
Why?
|
beta-Thalassemia | 17 | 2023 | 235 | 3.680 |
Why?
|
Anemia, Diamond-Blackfan | 10 | 2021 | 136 | 3.550 |
Why?
|
Hematologic Diseases | 8 | 2023 | 496 | 2.420 |
Why?
|
Repressor Proteins | 20 | 2022 | 2981 | 2.060 |
Why?
|
Hemoglobins | 10 | 2022 | 1521 | 2.000 |
Why?
|
DNA, Mitochondrial | 10 | 2024 | 858 | 1.840 |
Why?
|
Mutation, Missense | 10 | 2024 | 2566 | 1.750 |
Why?
|
beta-Globins | 10 | 2021 | 108 | 1.720 |
Why?
|
Erythroid Precursor Cells | 8 | 2019 | 211 | 1.590 |
Why?
|
Cell Lineage | 11 | 2024 | 2533 | 1.490 |
Why?
|
Anemia | 6 | 2022 | 1511 | 1.430 |
Why?
|
Gene Silencing | 9 | 2021 | 1513 | 1.420 |
Why?
|
Thrombopoietin | 3 | 2023 | 226 | 1.380 |
Why?
|
Erythrocytes | 7 | 2022 | 2415 | 1.380 |
Why?
|
Anemia, Sickle Cell | 11 | 2022 | 1056 | 1.370 |
Why?
|
Carrier Proteins | 14 | 2019 | 4938 | 1.360 |
Why?
|
Thalassemia | 3 | 2023 | 270 | 1.350 |
Why?
|
Cell Differentiation | 24 | 2023 | 11481 | 1.340 |
Why?
|
Erythropoietin | 5 | 2020 | 720 | 1.340 |
Why?
|
Gene Expression Regulation, Developmental | 12 | 2021 | 3604 | 1.330 |
Why?
|
Hemoglobinopathies | 5 | 2015 | 96 | 1.320 |
Why?
|
Nuclear Proteins | 15 | 2024 | 5791 | 1.310 |
Why?
|
Thrombocytopenia | 3 | 2023 | 1174 | 1.280 |
Why?
|
Single-Cell Analysis | 10 | 2024 | 2380 | 1.270 |
Why?
|
Mutation | 30 | 2024 | 29932 | 1.260 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 2 | 2019 | 15 | 1.170 |
Why?
|
Blood Cells | 4 | 2022 | 305 | 1.130 |
Why?
|
Genetic Diseases, Inborn | 4 | 2024 | 601 | 1.110 |
Why?
|
Mitochondria | 8 | 2023 | 3600 | 1.060 |
Why?
|
Genetic Predisposition to Disease | 13 | 2024 | 17790 | 1.050 |
Why?
|
Quantitative Trait Loci | 6 | 2022 | 2101 | 1.030 |
Why?
|
Pancytopenia | 2 | 2023 | 101 | 1.020 |
Why?
|
Chromatin | 12 | 2024 | 2938 | 0.940 |
Why?
|
Alternative Splicing | 3 | 2019 | 1091 | 0.920 |
Why?
|
Genome-Wide Association Study | 19 | 2023 | 12626 | 0.870 |
Why?
|
Gene Expression Regulation | 16 | 2023 | 11903 | 0.870 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2024 | 15789 | 0.870 |
Why?
|
Hematology | 2 | 2019 | 241 | 0.860 |
Why?
|
Transcription Factors | 16 | 2024 | 12103 | 0.820 |
Why?
|
Genomics | 7 | 2023 | 5794 | 0.820 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2019 | 503 | 0.770 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2022 | 132 | 0.770 |
Why?
|
Globins | 6 | 2021 | 403 | 0.760 |
Why?
|
Hematinics | 2 | 2015 | 281 | 0.760 |
Why?
|
Genetic Variation | 6 | 2024 | 6551 | 0.750 |
Why?
|
Trisomy | 3 | 2022 | 260 | 0.730 |
Why?
|
Chromosomes, Human, Pair 13 | 2 | 2011 | 193 | 0.730 |
Why?
|
Mosaicism | 2 | 2024 | 466 | 0.720 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2023 | 3616 | 0.720 |
Why?
|
Clone Cells | 6 | 2024 | 1660 | 0.710 |
Why?
|
Humans | 148 | 2024 | 760621 | 0.700 |
Why?
|
Ikaros Transcription Factor | 2 | 2024 | 231 | 0.690 |
Why?
|
Transcription, Genetic | 10 | 2024 | 7593 | 0.690 |
Why?
|
K562 Cells | 7 | 2021 | 640 | 0.670 |
Why?
|
Erythroid Cells | 6 | 2020 | 235 | 0.660 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2020 | 187 | 0.660 |
Why?
|
Proto-Oncogene Proteins | 5 | 2020 | 4490 | 0.650 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2020 | 193 | 0.650 |
Why?
|
Ribosomes | 3 | 2020 | 501 | 0.640 |
Why?
|
Introns | 2 | 2019 | 978 | 0.630 |
Why?
|
Anemia, Aplastic | 1 | 2020 | 228 | 0.630 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2020 | 146 | 0.630 |
Why?
|
Fanconi Anemia | 2 | 2019 | 324 | 0.610 |
Why?
|
Isoquinolines | 1 | 2020 | 353 | 0.610 |
Why?
|
Primary Myelofibrosis | 1 | 2020 | 210 | 0.600 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 724 | 0.590 |
Why?
|
Phenotype | 21 | 2024 | 16546 | 0.580 |
Why?
|
Ribosomal Proteins | 7 | 2021 | 363 | 0.570 |
Why?
|
Disease | 1 | 2022 | 671 | 0.560 |
Why?
|
Hemoglobin A | 2 | 2015 | 84 | 0.550 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2019 | 633 | 0.550 |
Why?
|
Base Sequence | 8 | 2022 | 12446 | 0.540 |
Why?
|
Glycine | 1 | 2020 | 662 | 0.540 |
Why?
|
Genetic Techniques | 2 | 2016 | 428 | 0.540 |
Why?
|
Cell Cycle | 4 | 2023 | 2934 | 0.520 |
Why?
|
Blood Transfusion, Autologous | 1 | 2016 | 132 | 0.520 |
Why?
|
Quantitative Trait, Heritable | 1 | 2019 | 540 | 0.520 |
Why?
|
HEK293 Cells | 7 | 2021 | 4264 | 0.510 |
Why?
|
Phosphoproteins | 2 | 2024 | 2440 | 0.510 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 286 | 0.510 |
Why?
|
Common Variable Immunodeficiency | 1 | 2016 | 102 | 0.500 |
Why?
|
Leukemia | 2 | 2024 | 1520 | 0.500 |
Why?
|
Cyclin A2 | 1 | 2015 | 21 | 0.500 |
Why?
|
Protein Biosynthesis | 4 | 2020 | 2105 | 0.490 |
Why?
|
Anemia, Macrocytic | 1 | 2015 | 54 | 0.490 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2019 | 241 | 0.490 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 1547 | 0.480 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 2015 | 64 | 0.480 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2021 | 1652 | 0.480 |
Why?
|
Response Elements | 1 | 2016 | 308 | 0.480 |
Why?
|
Chromosome Disorders | 2 | 2021 | 499 | 0.470 |
Why?
|
Myeloproliferative Disorders | 1 | 2020 | 609 | 0.470 |
Why?
|
SOXD Transcription Factors | 2 | 2011 | 44 | 0.460 |
Why?
|
Rare Diseases | 3 | 2024 | 619 | 0.460 |
Why?
|
Neoplasms | 7 | 2023 | 22072 | 0.460 |
Why?
|
Anemia, Neonatal | 1 | 2013 | 19 | 0.450 |
Why?
|
Cytokinesis | 1 | 2015 | 172 | 0.450 |
Why?
|
Cells, Cultured | 12 | 2021 | 18957 | 0.440 |
Why?
|
RNA-Binding Proteins | 3 | 2020 | 1894 | 0.440 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2017 | 727 | 0.440 |
Why?
|
Sequence Deletion | 2 | 2015 | 1493 | 0.440 |
Why?
|
Blood Platelets | 3 | 2019 | 2520 | 0.420 |
Why?
|
gamma-Globins | 5 | 2011 | 96 | 0.420 |
Why?
|
Cyclin D3 | 1 | 2012 | 54 | 0.420 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2013 | 73 | 0.420 |
Why?
|
Antisickling Agents | 1 | 2013 | 72 | 0.420 |
Why?
|
B-Lymphocytes | 3 | 2022 | 4742 | 0.410 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2022 | 2895 | 0.410 |
Why?
|
Genome | 2 | 2023 | 1739 | 0.400 |
Why?
|
Heterozygote | 2 | 2016 | 2798 | 0.390 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1895 | 0.390 |
Why?
|
Genetic Loci | 3 | 2016 | 2618 | 0.390 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 378 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2011 | 79 | 0.360 |
Why?
|
Family | 2 | 2019 | 3189 | 0.360 |
Why?
|
Bone Marrow Diseases | 2 | 2023 | 232 | 0.360 |
Why?
|
Computational Biology | 1 | 2022 | 3505 | 0.350 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4107 | 0.350 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2015 | 599 | 0.350 |
Why?
|
Hematopoietic Stem Cell Transplantation | 6 | 2020 | 5649 | 0.340 |
Why?
|
alpha-Globins | 3 | 2018 | 19 | 0.340 |
Why?
|
Animals | 39 | 2024 | 167963 | 0.340 |
Why?
|
Point Mutation | 1 | 2015 | 1594 | 0.340 |
Why?
|
Phloretin | 2 | 2019 | 16 | 0.340 |
Why?
|
RNA, Messenger | 5 | 2022 | 12766 | 0.330 |
Why?
|
Zinc Fingers | 2 | 2021 | 568 | 0.330 |
Why?
|
Receptors, Erythropoietin | 3 | 2019 | 144 | 0.320 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1394 | 0.320 |
Why?
|
Transcriptional Activation | 2 | 2013 | 1755 | 0.310 |
Why?
|
Infant, Premature, Diseases | 1 | 2013 | 708 | 0.290 |
Why?
|
Retinoblastoma Protein | 2 | 2008 | 670 | 0.290 |
Why?
|
DNA Copy Number Variations | 5 | 2024 | 2013 | 0.280 |
Why?
|
Epigenomics | 3 | 2022 | 936 | 0.270 |
Why?
|
Iron Overload | 2 | 2021 | 240 | 0.270 |
Why?
|
Pedigree | 4 | 2021 | 4578 | 0.270 |
Why?
|
Lipid Peroxidation | 2 | 2024 | 271 | 0.250 |
Why?
|
Multifactorial Inheritance | 3 | 2024 | 1365 | 0.250 |
Why?
|
Epigenesis, Genetic | 5 | 2020 | 3758 | 0.250 |
Why?
|
Child | 16 | 2024 | 79806 | 0.250 |
Why?
|
Erythroblasts | 5 | 2019 | 143 | 0.250 |
Why?
|
Genetic Association Studies | 5 | 2021 | 2717 | 0.240 |
Why?
|
Embryonic Development | 2 | 2022 | 716 | 0.240 |
Why?
|
Male | 40 | 2024 | 359744 | 0.240 |
Why?
|
Leukocytes | 2 | 2024 | 2026 | 0.230 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2019 | 788 | 0.230 |
Why?
|
Leukocyte Count | 2 | 2019 | 1600 | 0.230 |
Why?
|
Female | 37 | 2024 | 391270 | 0.230 |
Why?
|
Molecular Targeted Therapy | 3 | 2013 | 2803 | 0.220 |
Why?
|
MicroRNAs | 4 | 2020 | 3790 | 0.220 |
Why?
|
Chondroitinsulfatases | 1 | 2023 | 16 | 0.220 |
Why?
|
Mice | 22 | 2023 | 81208 | 0.220 |
Why?
|
Monosaccharide Transport Proteins | 2 | 2023 | 440 | 0.220 |
Why?
|
Signal Transduction | 8 | 2024 | 23376 | 0.220 |
Why?
|
Cell Line, Tumor | 4 | 2023 | 16939 | 0.210 |
Why?
|
Stem Cells | 1 | 2015 | 3523 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.200 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2022 | 48 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.200 |
Why?
|
Chromosomes, Human, X | 1 | 2024 | 321 | 0.200 |
Why?
|
Linkage Disequilibrium | 2 | 2019 | 1996 | 0.200 |
Why?
|
DNA-Binding Proteins | 6 | 2023 | 9585 | 0.200 |
Why?
|
Megakaryocytes | 3 | 2016 | 565 | 0.200 |
Why?
|
Cell Size | 2 | 2015 | 624 | 0.200 |
Why?
|
Gene Knockdown Techniques | 3 | 2016 | 1617 | 0.190 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2022 | 94 | 0.190 |
Why?
|
DNA, Intergenic | 1 | 2022 | 105 | 0.190 |
Why?
|
Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2021 | 8 | 0.190 |
Why?
|
Dihydroorotase | 1 | 2021 | 8 | 0.190 |
Why?
|
Aspartate Carbamoyltransferase | 1 | 2021 | 19 | 0.190 |
Why?
|
Lipomatosis | 1 | 2022 | 112 | 0.190 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2022 | 84 | 0.190 |
Why?
|
Antioxidants | 2 | 2019 | 1667 | 0.180 |
Why?
|
Chromosome Breakage | 1 | 2021 | 159 | 0.180 |
Why?
|
Genome, Human | 6 | 2024 | 4417 | 0.180 |
Why?
|
Epoetin Alfa | 1 | 2020 | 79 | 0.180 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2001 | 202 | 0.180 |
Why?
|
Genes, Switch | 2 | 2010 | 48 | 0.180 |
Why?
|
Uridine | 1 | 2021 | 143 | 0.180 |
Why?
|
Aneuploidy | 1 | 2024 | 551 | 0.180 |
Why?
|
Adult | 25 | 2024 | 219994 | 0.180 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2020 | 57 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.170 |
Why?
|
Child, Preschool | 10 | 2022 | 42063 | 0.170 |
Why?
|
Species Specificity | 3 | 2014 | 2418 | 0.170 |
Why?
|
Heme | 2 | 2019 | 313 | 0.170 |
Why?
|
Embryo, Mammalian | 3 | 2018 | 1674 | 0.170 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9411 | 0.170 |
Why?
|
Ankyrin Repeat | 1 | 2019 | 19 | 0.170 |
Why?
|
Chromosome Mapping | 2 | 2019 | 4625 | 0.170 |
Why?
|
Mitochondrial Diseases | 1 | 2023 | 340 | 0.170 |
Why?
|
Gene Deletion | 4 | 2018 | 2668 | 0.170 |
Why?
|
alpha-Thalassemia | 2 | 2018 | 52 | 0.170 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2022 | 858 | 0.160 |
Why?
|
RNA Polymerase II | 1 | 2023 | 537 | 0.160 |
Why?
|
Siblings | 2 | 2021 | 824 | 0.160 |
Why?
|
Pluripotent Stem Cells | 2 | 2016 | 792 | 0.160 |
Why?
|
Endopeptidases | 1 | 2023 | 772 | 0.160 |
Why?
|
Leukemia, Myeloid | 1 | 2022 | 695 | 0.160 |
Why?
|
Scurvy | 1 | 2019 | 35 | 0.160 |
Why?
|
Gene Regulatory Networks | 3 | 2022 | 1741 | 0.160 |
Why?
|
Transposases | 1 | 2019 | 103 | 0.160 |
Why?
|
Cation Transport Proteins | 1 | 2001 | 325 | 0.160 |
Why?
|
Benzoates | 1 | 2020 | 212 | 0.160 |
Why?
|
Hydrazines | 1 | 2020 | 224 | 0.160 |
Why?
|
Trans-Activators | 2 | 2023 | 2860 | 0.160 |
Why?
|
eIF-2 Kinase | 1 | 2019 | 144 | 0.160 |
Why?
|
Symporters | 1 | 2001 | 361 | 0.160 |
Why?
|
Receptors, Cytokine | 1 | 2019 | 258 | 0.150 |
Why?
|
Chromosomes | 1 | 2021 | 575 | 0.150 |
Why?
|
Plasma Cells | 1 | 2022 | 591 | 0.150 |
Why?
|
HeLa Cells | 2 | 2021 | 3105 | 0.150 |
Why?
|
Polymorphism, Genetic | 3 | 2022 | 4291 | 0.150 |
Why?
|
Mycophenolic Acid | 1 | 2020 | 343 | 0.150 |
Why?
|
Embryonic Stem Cells | 2 | 2015 | 1262 | 0.150 |
Why?
|
RNA Splice Sites | 1 | 2019 | 211 | 0.150 |
Why?
|
Protein Binding | 5 | 2019 | 9335 | 0.150 |
Why?
|
Chitosan | 1 | 2019 | 131 | 0.150 |
Why?
|
Developing Countries | 1 | 2010 | 2868 | 0.150 |
Why?
|
Hemoglobin, Sickle | 1 | 2018 | 113 | 0.150 |
Why?
|
Biomimetic Materials | 1 | 2019 | 173 | 0.150 |
Why?
|
Biological Evolution | 1 | 2023 | 1074 | 0.150 |
Why?
|
Sickle Cell Trait | 1 | 2018 | 85 | 0.150 |
Why?
|
Phospholipids | 1 | 2001 | 789 | 0.140 |
Why?
|
Cell Line | 4 | 2021 | 15620 | 0.140 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5785 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2016 | 12 | 0.140 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3442 | 0.140 |
Why?
|
Genetic Engineering | 1 | 2023 | 933 | 0.140 |
Why?
|
Estonia | 1 | 2016 | 54 | 0.140 |
Why?
|
Models, Biological | 5 | 2022 | 9467 | 0.140 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2020 | 557 | 0.140 |
Why?
|
Porphyrias | 1 | 2016 | 58 | 0.140 |
Why?
|
5' Untranslated Regions | 1 | 2018 | 256 | 0.140 |
Why?
|
Genes, myb | 2 | 2013 | 18 | 0.140 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 158 | 0.130 |
Why?
|
Sequence Analysis, DNA | 3 | 2024 | 4713 | 0.130 |
Why?
|
Exons | 2 | 2019 | 2388 | 0.130 |
Why?
|
Infant, Newborn | 5 | 2023 | 26181 | 0.130 |
Why?
|
Cell Membrane | 2 | 2023 | 3682 | 0.130 |
Why?
|
Databases, Nucleic Acid | 1 | 2016 | 204 | 0.130 |
Why?
|
Inosine | 1 | 2016 | 130 | 0.130 |
Why?
|
Megakaryocyte-Erythroid Progenitor Cells | 1 | 2015 | 10 | 0.130 |
Why?
|
Protein Engineering | 1 | 2019 | 541 | 0.130 |
Why?
|
Homeostasis | 2 | 2020 | 3306 | 0.130 |
Why?
|
RNA Interference | 2 | 2018 | 2846 | 0.130 |
Why?
|
Erythrocyte Transfusion | 1 | 2020 | 566 | 0.120 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2506 | 0.120 |
Why?
|
Mice, Knockout | 7 | 2020 | 14372 | 0.120 |
Why?
|
Pyridoxal Phosphate | 1 | 2015 | 124 | 0.120 |
Why?
|
Biomedical Research | 1 | 2010 | 3426 | 0.120 |
Why?
|
Consanguinity | 1 | 2017 | 456 | 0.120 |
Why?
|
RNA Editing | 1 | 2016 | 151 | 0.120 |
Why?
|
Iron | 2 | 2024 | 1786 | 0.120 |
Why?
|
Cell Transplantation | 1 | 2016 | 472 | 0.120 |
Why?
|
Genes, X-Linked | 1 | 2015 | 128 | 0.120 |
Why?
|
Basophils | 1 | 2016 | 404 | 0.120 |
Why?
|
Blood Transfusion | 3 | 2021 | 1328 | 0.120 |
Why?
|
Porphyrins | 1 | 2016 | 353 | 0.120 |
Why?
|
Genotype | 6 | 2023 | 12960 | 0.120 |
Why?
|
Reticulocytes | 1 | 2015 | 288 | 0.120 |
Why?
|
Adenosine Deaminase | 1 | 2016 | 251 | 0.110 |
Why?
|
Isoantigens | 1 | 2016 | 552 | 0.110 |
Why?
|
Down Syndrome | 1 | 2022 | 892 | 0.110 |
Why?
|
Peptide Elongation Factors | 1 | 2013 | 62 | 0.110 |
Why?
|
Evolution, Molecular | 2 | 2014 | 1885 | 0.110 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 542 | 0.110 |
Why?
|
Platelet Count | 1 | 2016 | 777 | 0.110 |
Why?
|
Kinetics | 2 | 2022 | 6377 | 0.110 |
Why?
|
Gene Library | 1 | 2016 | 1060 | 0.110 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2020 | 2290 | 0.110 |
Why?
|
Doxycycline | 1 | 2015 | 341 | 0.110 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2015 | 177 | 0.110 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2016 | 563 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1575 | 0.110 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1837 | 0.110 |
Why?
|
X Chromosome Inactivation | 1 | 2015 | 226 | 0.100 |
Why?
|
Blotting, Western | 4 | 2016 | 5039 | 0.100 |
Why?
|
Receptors, Transferrin | 2 | 2011 | 291 | 0.100 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1135 | 0.100 |
Why?
|
Recombinant Proteins | 2 | 2020 | 6538 | 0.100 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 373 | 0.100 |
Why?
|
Fetal Blood | 2 | 2016 | 1343 | 0.100 |
Why?
|
Gene Expression | 3 | 2021 | 7588 | 0.100 |
Why?
|
Genes, Reporter | 1 | 2016 | 1529 | 0.100 |
Why?
|
Genes, Dominant | 1 | 2015 | 863 | 0.100 |
Why?
|
Infant | 5 | 2020 | 36060 | 0.100 |
Why?
|
Mice, SCID | 1 | 2017 | 2627 | 0.100 |
Why?
|
Regenerative Medicine | 1 | 2015 | 307 | 0.100 |
Why?
|
Puerperal Disorders | 1 | 2015 | 300 | 0.100 |
Why?
|
Morbidity | 2 | 2021 | 1765 | 0.100 |
Why?
|
Binding Sites | 2 | 2020 | 6048 | 0.100 |
Why?
|
Risk | 2 | 2021 | 9631 | 0.100 |
Why?
|
Hydroxyurea | 1 | 2013 | 282 | 0.100 |
Why?
|
Cohort Studies | 9 | 2024 | 41335 | 0.100 |
Why?
|
Oxygen | 2 | 2020 | 4193 | 0.100 |
Why?
|
Transcriptional Elongation Factors | 2 | 2023 | 163 | 0.100 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2013 | 397 | 0.100 |
Why?
|
Conserved Sequence | 1 | 2014 | 1167 | 0.090 |
Why?
|
Adenosine | 1 | 2016 | 834 | 0.090 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2116 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1869 | 0.090 |
Why?
|
Azacitidine | 1 | 2013 | 334 | 0.090 |
Why?
|
Transfection | 1 | 2019 | 5781 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2017 | 3602 | 0.090 |
Why?
|
Molecular Sequence Data | 3 | 2015 | 17624 | 0.090 |
Why?
|
Professional Practice | 1 | 2013 | 313 | 0.090 |
Why?
|
Sri Lanka | 1 | 2010 | 92 | 0.090 |
Why?
|
Physical Chromosome Mapping | 1 | 2010 | 182 | 0.090 |
Why?
|
Prenatal Care | 1 | 2018 | 1129 | 0.090 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 2414 | 0.090 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1628 | 0.090 |
Why?
|
Lymphopoiesis | 1 | 2011 | 133 | 0.090 |
Why?
|
Flow Cytometry | 5 | 2016 | 5870 | 0.090 |
Why?
|
Neutrophils | 1 | 2023 | 3767 | 0.090 |
Why?
|
Proteins | 3 | 2021 | 6029 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1356 | 0.090 |
Why?
|
Germ-Line Mutation | 3 | 2024 | 1841 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1139 | 0.090 |
Why?
|
Iron Chelating Agents | 1 | 2010 | 138 | 0.090 |
Why?
|
Proteomics | 1 | 2023 | 3817 | 0.080 |
Why?
|
Pyrazoles | 1 | 2020 | 1999 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2022 | 3610 | 0.080 |
Why?
|
Codon, Nonsense | 1 | 2010 | 281 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10181 | 0.080 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 951 | 0.080 |
Why?
|
Models, Animal | 2 | 2018 | 2117 | 0.080 |
Why?
|
Histones | 3 | 2014 | 2583 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2592 | 0.080 |
Why?
|
Adolescent | 8 | 2024 | 87810 | 0.080 |
Why?
|
Integrases | 2 | 2008 | 516 | 0.080 |
Why?
|
Zebrafish | 2 | 2020 | 2997 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1664 | 0.080 |
Why?
|
Cell Communication | 1 | 2016 | 1653 | 0.080 |
Why?
|
Cell Count | 1 | 2012 | 1835 | 0.080 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2008 | 114 | 0.080 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 2 | 2020 | 322 | 0.070 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2022 | 568 | 0.070 |
Why?
|
Models, Genetic | 2 | 2024 | 3442 | 0.070 |
Why?
|
Mammals | 2 | 2023 | 1131 | 0.070 |
Why?
|
Software | 1 | 2021 | 4419 | 0.070 |
Why?
|
Biological Specimen Banks | 2 | 2024 | 783 | 0.070 |
Why?
|
Nanoparticles | 1 | 2019 | 1943 | 0.070 |
Why?
|
Down-Regulation | 2 | 2019 | 2913 | 0.070 |
Why?
|
Bone Marrow | 2 | 2023 | 2912 | 0.070 |
Why?
|
Protein Conformation | 1 | 2015 | 3969 | 0.070 |
Why?
|
Aging | 2 | 2024 | 8651 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1974 | 0.070 |
Why?
|
Genetic Testing | 3 | 2024 | 3531 | 0.070 |
Why?
|
Young Adult | 9 | 2024 | 58741 | 0.070 |
Why?
|
Apoptosis | 2 | 2020 | 9501 | 0.070 |
Why?
|
Models, Molecular | 2 | 2015 | 5434 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 3150 | 0.060 |
Why?
|
Genes, p53 | 1 | 2008 | 713 | 0.060 |
Why?
|
Alleles | 3 | 2024 | 6898 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2010 | 1204 | 0.060 |
Why?
|
Multigene Family | 1 | 2008 | 1077 | 0.060 |
Why?
|
Translocation, Genetic | 1 | 2011 | 1388 | 0.060 |
Why?
|
Antigens, CD34 | 2 | 2022 | 653 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3775 | 0.060 |
Why?
|
Pregnancy | 2 | 2018 | 29749 | 0.060 |
Why?
|
Cytokines | 2 | 2019 | 7343 | 0.060 |
Why?
|
Middle Aged | 9 | 2024 | 220352 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7064 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2008 | 718 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2008 | 1697 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 1827 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2022 | 5130 | 0.060 |
Why?
|
Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.060 |
Why?
|
Up-Regulation | 1 | 2013 | 4122 | 0.060 |
Why?
|
Aged | 7 | 2023 | 169152 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4573 | 0.060 |
Why?
|
Chromosomes, Human, Y | 1 | 2024 | 162 | 0.050 |
Why?
|
Chromosome Segregation | 1 | 2024 | 233 | 0.050 |
Why?
|
DNA Modification Methylases | 1 | 2023 | 209 | 0.050 |
Why?
|
Hemorrhage | 1 | 2015 | 3600 | 0.050 |
Why?
|
F-Box Proteins | 1 | 2024 | 202 | 0.050 |
Why?
|
Receptor, EphB3 | 1 | 2022 | 11 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2005 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2023 | 58995 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2008 | 2381 | 0.050 |
Why?
|
Osteosarcoma | 1 | 2008 | 897 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2019 | 7850 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1599 | 0.050 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2022 | 81 | 0.050 |
Why?
|
Fetus | 1 | 2009 | 1859 | 0.050 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2022 | 63 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2011 | 9530 | 0.050 |
Why?
|
Antiporters | 1 | 2023 | 278 | 0.050 |
Why?
|
DNA Methylation | 2 | 2013 | 4373 | 0.050 |
Why?
|
HL-60 Cells | 1 | 2022 | 363 | 0.050 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2022 | 225 | 0.050 |
Why?
|
Polymerase Chain Reaction | 3 | 2016 | 6068 | 0.050 |
Why?
|
alpha Karyopherins | 1 | 2020 | 40 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6544 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2016 | 10446 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2021 | 2176 | 0.040 |
Why?
|
Inositol Phosphates | 1 | 2000 | 176 | 0.040 |
Why?
|
Bone and Bones | 1 | 2011 | 2560 | 0.040 |
Why?
|
Genome, Mitochondrial | 1 | 2020 | 66 | 0.040 |
Why?
|
Mortality | 2 | 2021 | 2916 | 0.040 |
Why?
|
Antigens, CD | 1 | 2011 | 4000 | 0.040 |
Why?
|
MELAS Syndrome | 1 | 2020 | 56 | 0.040 |
Why?
|
Interleukin-7 | 1 | 2020 | 142 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2001 | 1142 | 0.040 |
Why?
|
Genetics | 1 | 2020 | 114 | 0.040 |
Why?
|
Calmodulin | 1 | 2020 | 217 | 0.040 |
Why?
|
Inheritance Patterns | 1 | 2022 | 340 | 0.040 |
Why?
|
GRB10 Adaptor Protein | 1 | 2019 | 23 | 0.040 |
Why?
|
Phosphatidylinositols | 1 | 2000 | 282 | 0.040 |
Why?
|
Glutathione Transferase | 1 | 2001 | 565 | 0.040 |
Why?
|
Inflammation | 2 | 2019 | 10756 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6853 | 0.040 |
Why?
|
Blood Proteins | 2 | 2001 | 1173 | 0.040 |
Why?
|
Activating Transcription Factor 4 | 1 | 2019 | 82 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2021 | 219 | 0.040 |
Why?
|
Ribosome Subunits, Large | 1 | 2018 | 4 | 0.040 |
Why?
|
Cytochromes c | 1 | 2019 | 173 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2023 | 595 | 0.040 |
Why?
|
Africa | 1 | 2020 | 705 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 335 | 0.040 |
Why?
|
Microscopy | 1 | 2023 | 885 | 0.040 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2019 | 180 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39261 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 1 | 2019 | 282 | 0.040 |
Why?
|
United States | 3 | 2020 | 72461 | 0.040 |
Why?
|
Erythrocytes, Abnormal | 1 | 2018 | 121 | 0.040 |
Why?
|
Liposomes | 1 | 2001 | 777 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2022 | 1089 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15840 | 0.040 |
Why?
|
Protein Stability | 1 | 2019 | 566 | 0.040 |
Why?
|
Causality | 1 | 2023 | 1242 | 0.040 |
Why?
|
Unfolded Protein Response | 1 | 2019 | 233 | 0.040 |
Why?
|
Caspase 3 | 1 | 2019 | 731 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2019 | 412 | 0.030 |
Why?
|
Syndrome | 1 | 2023 | 3280 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7408 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2022 | 727 | 0.030 |
Why?
|
Algorithms | 2 | 2022 | 13981 | 0.030 |
Why?
|
Schizophrenia | 1 | 2015 | 6915 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2016 | 2753 | 0.030 |
Why?
|
Receptors, Interferon | 1 | 2016 | 116 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2016 | 351 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2138 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2008 | 2532 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2016 | 2698 | 0.030 |
Why?
|
Atrophy | 1 | 2021 | 1627 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13630 | 0.030 |
Why?
|
Erythrocyte Indices | 1 | 2016 | 145 | 0.030 |
Why?
|
Myelopoiesis | 1 | 2016 | 134 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20509 | 0.030 |
Why?
|
Cricetinae | 1 | 2019 | 2427 | 0.030 |
Why?
|
Lipoproteins | 1 | 2000 | 882 | 0.030 |
Why?
|
Retroelements | 1 | 2016 | 163 | 0.030 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2019 | 368 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 473 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2012 | 22053 | 0.030 |
Why?
|
Granulocytes | 1 | 2016 | 551 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3800 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2016 | 877 | 0.030 |
Why?
|
Ubiquitination | 1 | 2019 | 1008 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1871 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 983 | 0.030 |
Why?
|
Mouth Neoplasms | 1 | 2019 | 593 | 0.030 |
Why?
|
Computer Simulation | 2 | 2022 | 6218 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2015 | 330 | 0.030 |
Why?
|
Pain | 1 | 2008 | 5066 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 852 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 730 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2023 | 2754 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3735 | 0.030 |
Why?
|
Interferons | 1 | 2016 | 705 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1407 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2471 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3276 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18137 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2021 | 1504 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2250 | 0.020 |
Why?
|
Biological Transport | 1 | 2016 | 2086 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1955 | 0.020 |
Why?
|
Prognosis | 2 | 2022 | 29658 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4035 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2014 | 747 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2608 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2000 | 2864 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2514 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3725 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8515 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2873 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3446 | 0.020 |
Why?
|
Blotting, Southern | 1 | 2010 | 777 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2020 | 2919 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 22023 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 2180 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9716 | 0.020 |
Why?
|
Parents | 1 | 2023 | 3549 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 80372 | 0.020 |
Why?
|
Forecasting | 1 | 2018 | 2932 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13502 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8313 | 0.020 |
Why?
|
Mesoderm | 1 | 2011 | 672 | 0.020 |
Why?
|
Lentivirus | 1 | 2010 | 506 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6216 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2011 | 580 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12531 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65017 | 0.020 |
Why?
|
Italy | 1 | 2008 | 841 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4090 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 1720 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2298 | 0.020 |
Why?
|
Protein Transport | 1 | 2010 | 1964 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3804 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 4024 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 3763 | 0.010 |
Why?
|
Tumor Burden | 1 | 2008 | 1895 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 74359 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2010 | 3380 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11712 | 0.010 |
Why?
|
Gene Frequency | 1 | 2008 | 3615 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 24123 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5889 | 0.010 |
Why?
|
Hydrogen Bonding | 1 | 2000 | 291 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20080 | 0.010 |
Why?
|
src Homology Domains | 1 | 2000 | 361 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4902 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2000 | 1229 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1792 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2000 | 1982 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15757 | 0.010 |
Why?
|
Fatty Acids | 1 | 2000 | 1804 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25942 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13451 | 0.000 |
Why?
|